Hemagglutinin 5 Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: H6DB9F9591CAEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Hemagglutinin 5 in Global, including the following market information:

Global Hemagglutinin 5 Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hemagglutinin 5 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

VGX-3400X Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hemagglutinin 5 include Altravax, Inc., Ilyang Pharmaceutical Co., Ltd, Inovio Pharmaceuticals, Inc., NewLink Genetics Corporation and Vaxine Pty Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemagglutinin 5 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hemagglutinin 5 Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hemagglutinin 5 Market Segment Percentages, by Type, 2021 (%)

• VGX-3400X
• IY-7640
• INO-3510
• DPC-005
• Others

Global Hemagglutinin 5 Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hemagglutinin 5 Market Segment Percentages, by Application, 2021 (%)

• Clinic
• Hospital
• House Use

Global Hemagglutinin 5 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hemagglutinin 5 Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hemagglutinin 5 revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hemagglutinin 5 revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Altravax, Inc.
• Ilyang Pharmaceutical Co., Ltd
• Inovio Pharmaceuticals, Inc.
• NewLink Genetics Corporation
• Vaxine Pty Ltd

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hemagglutinin 5 Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hemagglutinin 5 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEMAGGLUTININ 5 OVERALL MARKET SIZE

2.1 Global Hemagglutinin 5 Market Size: 2021 VS 2028
2.2 Global Hemagglutinin 5 Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hemagglutinin 5 Players in Global Market
3.2 Top Global Hemagglutinin 5 Companies Ranked by Revenue
3.3 Global Hemagglutinin 5 Revenue by Companies
3.4 Top 3 and Top 5 Hemagglutinin 5 Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hemagglutinin 5 Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hemagglutinin 5 Players in Global Market
  3.6.1 List of Global Tier 1 Hemagglutinin 5 Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hemagglutinin 5 Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hemagglutinin 5 Market Size Markets, 2021 & 2028
  4.1.2 VGX-3400X
  4.1.3 IY-7640
  4.1.4 INO-3510
  4.1.5 DPC-005
  4.1.6 Others
4.2 By Type - Global Hemagglutinin 5 Revenue & Forecasts
  4.2.1 By Type - Global Hemagglutinin 5 Revenue, 2017-2022
  4.2.2 By Type - Global Hemagglutinin 5 Revenue, 2023-2028
  4.2.3 By Type - Global Hemagglutinin 5 Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hemagglutinin 5 Market Size, 2021 & 2028
  5.1.2 Clinic
  5.1.3 Hospital
  5.1.4 House Use
5.2 By Application - Global Hemagglutinin 5 Revenue & Forecasts
  5.2.1 By Application - Global Hemagglutinin 5 Revenue, 2017-2022
  5.2.2 By Application - Global Hemagglutinin 5 Revenue, 2023-2028
  5.2.3 By Application - Global Hemagglutinin 5 Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hemagglutinin 5 Market Size, 2021 & 2028
6.2 By Region - Global Hemagglutinin 5 Revenue & Forecasts
  6.2.1 By Region - Global Hemagglutinin 5 Revenue, 2017-2022
  6.2.2 By Region - Global Hemagglutinin 5 Revenue, 2023-2028
  6.2.3 By Region - Global Hemagglutinin 5 Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hemagglutinin 5 Revenue, 2017-2028
  6.3.2 US Hemagglutinin 5 Market Size, 2017-2028
  6.3.3 Canada Hemagglutinin 5 Market Size, 2017-2028
  6.3.4 Mexico Hemagglutinin 5 Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hemagglutinin 5 Revenue, 2017-2028
  6.4.2 Germany Hemagglutinin 5 Market Size, 2017-2028
  6.4.3 France Hemagglutinin 5 Market Size, 2017-2028
  6.4.4 U.K. Hemagglutinin 5 Market Size, 2017-2028
  6.4.5 Italy Hemagglutinin 5 Market Size, 2017-2028
  6.4.6 Russia Hemagglutinin 5 Market Size, 2017-2028
  6.4.7 Nordic Countries Hemagglutinin 5 Market Size, 2017-2028
  6.4.8 Benelux Hemagglutinin 5 Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hemagglutinin 5 Revenue, 2017-2028
  6.5.2 China Hemagglutinin 5 Market Size, 2017-2028
  6.5.3 Japan Hemagglutinin 5 Market Size, 2017-2028
  6.5.4 South Korea Hemagglutinin 5 Market Size, 2017-2028
  6.5.5 Southeast Asia Hemagglutinin 5 Market Size, 2017-2028
  6.5.6 India Hemagglutinin 5 Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hemagglutinin 5 Revenue, 2017-2028
  6.6.2 Brazil Hemagglutinin 5 Market Size, 2017-2028
  6.6.3 Argentina Hemagglutinin 5 Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hemagglutinin 5 Revenue, 2017-2028
  6.7.2 Turkey Hemagglutinin 5 Market Size, 2017-2028
  6.7.3 Israel Hemagglutinin 5 Market Size, 2017-2028
  6.7.4 Saudi Arabia Hemagglutinin 5 Market Size, 2017-2028
  6.7.5 UAE Hemagglutinin 5 Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Altravax, Inc.
  7.1.1 Altravax, Inc. Corporate Summary
  7.1.2 Altravax, Inc. Business Overview
  7.1.3 Altravax, Inc. Hemagglutinin 5 Major Product Offerings
  7.1.4 Altravax, Inc. Hemagglutinin 5 Revenue in Global Market (2017-2022)
  7.1.5 Altravax, Inc. Key News
7.2 Ilyang Pharmaceutical Co., Ltd
  7.2.1 Ilyang Pharmaceutical Co., Ltd Corporate Summary
  7.2.2 Ilyang Pharmaceutical Co., Ltd Business Overview
  7.2.3 Ilyang Pharmaceutical Co., Ltd Hemagglutinin 5 Major Product Offerings
  7.2.4 Ilyang Pharmaceutical Co., Ltd Hemagglutinin 5 Revenue in Global Market (2017-2022)
  7.2.5 Ilyang Pharmaceutical Co., Ltd Key News
7.3 Inovio Pharmaceuticals, Inc.
  7.3.1 Inovio Pharmaceuticals, Inc. Corporate Summary
  7.3.2 Inovio Pharmaceuticals, Inc. Business Overview
  7.3.3 Inovio Pharmaceuticals, Inc. Hemagglutinin 5 Major Product Offerings
  7.3.4 Inovio Pharmaceuticals, Inc. Hemagglutinin 5 Revenue in Global Market (2017-2022)
  7.3.5 Inovio Pharmaceuticals, Inc. Key News
7.4 NewLink Genetics Corporation
  7.4.1 NewLink Genetics Corporation Corporate Summary
  7.4.2 NewLink Genetics Corporation Business Overview
  7.4.3 NewLink Genetics Corporation Hemagglutinin 5 Major Product Offerings
  7.4.4 NewLink Genetics Corporation Hemagglutinin 5 Revenue in Global Market (2017-2022)
  7.4.5 NewLink Genetics Corporation Key News
7.5 Vaxine Pty Ltd
  7.5.1 Vaxine Pty Ltd Corporate Summary
  7.5.2 Vaxine Pty Ltd Business Overview
  7.5.3 Vaxine Pty Ltd Hemagglutinin 5 Major Product Offerings
  7.5.4 Vaxine Pty Ltd Hemagglutinin 5 Revenue in Global Market (2017-2022)
  7.5.5 Vaxine Pty Ltd Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hemagglutinin 5 Market Opportunities & Trends in Global Market
Table 2. Hemagglutinin 5 Market Drivers in Global Market
Table 3. Hemagglutinin 5 Market Restraints in Global Market
Table 4. Key Players of Hemagglutinin 5 in Global Market
Table 5. Top Hemagglutinin 5 Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hemagglutinin 5 Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hemagglutinin 5 Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hemagglutinin 5 Product Type
Table 9. List of Global Tier 1 Hemagglutinin 5 Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hemagglutinin 5 Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hemagglutinin 5 Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hemagglutinin 5 Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hemagglutinin 5 Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hemagglutinin 5 Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hemagglutinin 5 Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hemagglutinin 5 Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hemagglutinin 5 Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hemagglutinin 5 Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hemagglutinin 5 Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hemagglutinin 5 Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hemagglutinin 5 Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hemagglutinin 5 Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hemagglutinin 5 Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hemagglutinin 5 Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hemagglutinin 5 Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hemagglutinin 5 Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hemagglutinin 5 Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hemagglutinin 5 Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hemagglutinin 5 Revenue, (US$, Mn), 2023-2028
Table 30. Altravax, Inc. Corporate Summary
Table 31. Altravax, Inc. Hemagglutinin 5 Product Offerings
Table 32. Altravax, Inc. Hemagglutinin 5 Revenue (US$, Mn), (2017-2022)
Table 33. Ilyang Pharmaceutical Co., Ltd Corporate Summary
Table 34. Ilyang Pharmaceutical Co., Ltd Hemagglutinin 5 Product Offerings
Table 35. Ilyang Pharmaceutical Co., Ltd Hemagglutinin 5 Revenue (US$, Mn), (2017-2022)
Table 36. Inovio Pharmaceuticals, Inc. Corporate Summary
Table 37. Inovio Pharmaceuticals, Inc. Hemagglutinin 5 Product Offerings
Table 38. Inovio Pharmaceuticals, Inc. Hemagglutinin 5 Revenue (US$, Mn), (2017-2022)
Table 39. NewLink Genetics Corporation Corporate Summary
Table 40. NewLink Genetics Corporation Hemagglutinin 5 Product Offerings
Table 41. NewLink Genetics Corporation Hemagglutinin 5 Revenue (US$, Mn), (2017-2022)
Table 42. Vaxine Pty Ltd Corporate Summary
Table 43. Vaxine Pty Ltd Hemagglutinin 5 Product Offerings
Table 44. Vaxine Pty Ltd Hemagglutinin 5 Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hemagglutinin 5 Segment by Type in 2021
Figure 2. Hemagglutinin 5 Segment by Application in 2021
Figure 3. Global Hemagglutinin 5 Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hemagglutinin 5 Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hemagglutinin 5 Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hemagglutinin 5 Revenue in 2021
Figure 8. By Type - Global Hemagglutinin 5 Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hemagglutinin 5 Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hemagglutinin 5 Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hemagglutinin 5 Revenue Market Share, 2017-2028
Figure 12. US Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hemagglutinin 5 Revenue Market Share, 2017-2028
Figure 16. Germany Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 17. France Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hemagglutinin 5 Revenue Market Share, 2017-2028
Figure 24. China Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 28. India Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hemagglutinin 5 Revenue Market Share, 2017-2028
Figure 30. Brazil Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hemagglutinin 5 Revenue Market Share, 2017-2028
Figure 33. Turkey Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hemagglutinin 5 Revenue, (US$, Mn), 2017-2028
Figure 37. Altravax, Inc. Hemagglutinin 5 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Ilyang Pharmaceutical Co., Ltd Hemagglutinin 5 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Inovio Pharmaceuticals, Inc. Hemagglutinin 5 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. NewLink Genetics Corporation Hemagglutinin 5 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Vaxine Pty Ltd Hemagglutinin 5 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)